基于血液动力学评估和管理心脏性休克
Jaime Hernandez-Montfort1, Diana Miranda2, Varinder Kaur Randhawa3
1Department of Medicine, Division of Cardiology, Baylor Scott and White Health Temple, TX.
US cardiology
|November 27, 2024
概括
心脏性休克 (CS) 是一种严重的疾病,由于血液流动不良而导致器官损伤. 这项研究提出了一个适应模型,用于早期识别和管理CS患者的过渡.
科学领域:
- 心脏病学 心脏病学
- 关键护理医学 关键护理医学
- 卫生系统科学 卫生系统科学
背景情况:
- 心脏性休克 (CS) 是一种危及生命的疾病,其特点是低输血和末端器官功能障碍.
- 由于其复杂的病理生理学和异质性,CS的管理存在重大挑战.
- 有效的CS护理需要对血液动力学管理采取系统的方法.
研究的目的:
- 提出一种适应性的,纵向的情境意识模型,用于管理心脏性休克.
- 概述在CS患者护理中基于血液动力学的系统性转换的考虑因素.
- 解决从细胞到医疗保健系统层面的CS管理中的可扩展异质性.
主要方法:
- 该研究提出了CS护理的概念模型,强调了自适应的纵向情境意识.
- 它讨论了基于血液动力学监测和患者状态的系统过渡.
- 研究了将细胞层面的见解与医疗保健系统物流整合的考虑因素.
主要成果:
- 拟议的模型有助于早期识别和在CS患者管理中的快速过渡.
- 它为解决不同护理环境中CS异质性的问题提供了一个框架.
- 该模型旨在优化CS的资源利用和临床决策.
结论:
- 适应性情境意识模型可以指导心脏性休克的系统血液动力学管理.
- 需要进一步的研究,以优化药物和设备战略在CS的综合卫生系统内.
- 实施这些模型可能会改善这种关键病情的患者的治疗结果.
相关概念视频
Blood Pressure Imbalances and Circulatory Shock
753
Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
753
Pericarditis IV: Nursing Management
2
Pericarditis, an inflammation of the pericardium, necessitates diligent nursing management to ensure effective patient care and recovery. The initial step in managing pericarditis is a comprehensive patient medical assessment.The patient reports chest pain aggravated by breathing, coughing, and swallowing, which worsens when lying supine. The pain often improves when sitting up and leaning forward. Additional symptoms may include fever, malaise, and, in severe cases, signs of heart failure.
2
Rheumatic Heart Disease IV: Nursing Management
4
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
4
Aortic Regurgitation IV: Nursing Management
12
A nurse managing a patient with aortic regurgitation begins with a comprehensive assessment, including a review of the patient's medical history, family history, and lifestyle factors. During the cardiac examination, the nurse listens for heart sounds and checks for signs of valve abnormalities. The nurse also observes for symptoms such as dyspnea, orthopnea, and paroxysmal nocturnal dyspnea and assesses the patient's endurance and daily activity tolerance.Based on the findings, the nurse...
12
Mitral Regurgitation IV: Nursing Management
3
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
3
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
386
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
386


